Idlir Licaj

5PUBLICATIONS
19CO-AUTHORS
Infant and child healthPredictive and prognostic markersAnimal immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 06, 2025
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes.

Stephen E Gitelman, Kimber Simmons, Jennifer L Sherr

|Oct 21, 2025
Working conditions associated with return to work 2 years after breast cancer: insights from a cohort study.

Garazi Ruiz de Azua, Idlir Licaj, Sandrine Pinto

|May 13, 2023
Deep Learning Denoising Improves and Homogenizes Patient [18F]FDG PET Image Quality in Digital PET/CT.

Kathleen Weyts, Elske Quak, Idlir Licaj

|Jan 16, 2023
Baseline quality of life and chemotherapy toxicities in patients with early breast cancer.

Idlir Licaj, Elodie Coquan, Tienhan Sandrine Dabakuyo-Yonli

Pageof 1